methotrexate has been researched along with Bilateral Diffuse Uveal Melanocytic Proliferation, Paraneoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, A; Gupta, V; Testi, I | 1 |
| Jampol, LM; Leskov, I; Lyon, AT | 1 |
2 other study(ies) available for methotrexate and Bilateral Diffuse Uveal Melanocytic Proliferation, Paraneoplastic
| Article | Year |
|---|---|
Neoplastic lymphomatous submaculopathy.
Topics: Antimetabolites, Antineoplastic; Female; Fluorescein Angiography; Humans; Intraocular Lymphoma; Intravitreal Injections; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Paraneoplastic Syndromes, Ocular; Retinal Neoplasms; Tomography, Optical Coherence; Visual Acuity | 2019 |
Diffuse Uveal Melanocytic Proliferation With Primary Vitreoretinal Lymphoma.
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Cell Proliferation; Female; Fluorescein Angiography; Humans; Infusions, Intravenous; Intravitreal Injections; Lymphoma, Large B-Cell, Diffuse; Melanocytes; Methotrexate; Middle Aged; Neoplasm Proteins; Paraneoplastic Syndromes, Ocular; Retinal Neoplasms; Tomography, Optical Coherence; Uvea; Visual Acuity; Vitreous Body | 2019 |